BIOREPOSITORY PROTOCOL EXEMPT FROM NCI REPORTING

Cancer
Angela Fleischman
[BIOREPOSITORY] Hematologic Malignancies Biorepository for human research
Hodgkin's Lymphoma
Leukemia other
Lymphoid Leukemia
Multiple Myeloma
Mycosis Fungoides
Myeloid and Monocytic Leukemia
Non-Hodgkin's Lymphoma
Other Hematopoietic

Study Description

UC Irvine Medical Center is both a treatment and a research hospital. As a patient here, you may be treated

by some doctors who are also researchers performing studies to improve treatments currently available.

Scientists and clinicians at this institution are working together to discover new ways to treat cancer and

new ways to make current treatments safer and more effective. In order to conduct this research, we need

to study samples of normal and disease tissue obtained from normal volunteers and our patients. In order

to minimize the discomfort and risk to subjects, we are seeking to collect tissue that is left over from studies

that are required for your evaluation and care and are already being done. In certain circumstances (blood

draw and bone marrow aspiration) we are seeking to collect a small amount of tissue in addition to the

sample that would be collected for your routine care. Except for giving samples of blood, you will not be

asked to undergo any procedure solely for the purpose of obtaining a sample for this study.

You are being asked to take part in this research study because you have or are being evaluated for a

hematologic malignancy, bone marrow disorder, or immune system disorder.

This research study involves the collection and storage of blood and other tissue for later research testing.

It is not currently known how samples donated to the repository will be used at this time. These research tests may be developed during the time you are a patient at UC Irvine Medical Center, or in some cases, years later. Any researcher at UCI or their collaborators (including for-profit entities) may request permission to use samples from the repository. Frozen de-identified samples will be provided to researchers after their plans have been evaluated and approved by the UCI review board that oversees human research (IRB). These tests may provide additional information that will be helpful in understanding cancer and other diseases, but it is unlikely that what we learn from these studies will benefit you directly.

These studies may benefit other patients in the future. The research performed on these samples may

include the study of genetics, including the subject’s DNA code, parts or the DNA code or even whole

genome sequencing. Samples from the repository will not be used to create cell lines.

Eligibility

You can participate in this study if you have or are being evaluated for a blood disorder

You cannot participate in this study if you are pregnant.

A female nurse attentively holds a tablet, ready to assist with patient care and medical information.

Interested in Participating in this Trial?

Thank you for your interest with our team.

One of our specialists will be in contact with you soon.